Development and validation of a metastasis-associated prognostic signature based on single-cell RNA-seq in clear cell renal cell carcinoma C Zhang, H He, X Hu, A Liu, D Huang, Y Xu, L Chen, D Xu Aging (Albany NY) 11 (22), 10183-10202, 2019 | 39 | 2019 |
Socioeconomic factors are associated with the prognosis of Thyroid Cancer Y Li, D Huang, B Wang, W Mao, X Chen, P Dong Journal of Cancer 12 (9), 2507, 2021 | 19 | 2021 |
Enhanced recovery after surgery (ERAS) pathway optimizes outcomes and costs for minimally invasive radical prostatectomy Y Xu, A Liu, L Chen, H Huang, Y Gao, C Zhang, Y Xu, D Huang, D Xu, ... Journal of International Medical Research 48 (6), 0300060520920072, 2020 | 16 | 2020 |
Cannabis use is associated with lower COVID-19 susceptibility but poorer survival D Huang, R Xu, R Na Frontiers in Public Health 10, 829715, 2022 | 13 | 2022 |
Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy D Huang, X Yang, Y Wu, X Lin, D Xu, R Na, J Xu Frontiers in Oncology 10, 565382, 2020 | 13 | 2020 |
Genome‐wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma C Zhang, D Huang, A Liu, Y Xu, R Na, D Xu Journal of Cellular Biochemistry 121 (3), 2559-2570, 2019 | 12 | 2019 |
Targeting POLE2 Creates a Novel Vulnerability in Renal Cell Carcinoma via Modulating Stanniocalcin 1 C Zhang, Y Shen, L Gao, X Wang, D Huang, X Xie, D Xu, H He Frontiers in cell and developmental biology 9, 622344, 2021 | 11 | 2021 |
Family history is significantly associated with prostate cancer and its early onset in Chinese population Y Xu, D Huang, Y Wu, D Ye, N Zhang, Y Gao, D Xu, R Na, J Xu The Prostate 79 (15), 1762-1766, 2019 | 11 | 2019 |
Gender Gap in Industry Relationships and Scholarly Impact Among Academic Urologists in the United States NM Pace, A Maganty, N Siripong, AJ Lee, D Huang, J Bandari, BL Jacobs, ... Urology 139, 90-96, 2020 | 10 | 2020 |
Association between cannabis use with urological cancers: A population‐based cohort study and a mendelian randomization study in the UK biobank J Huang, D Huang, X Ruan, J Huang, D Xu, S Heavey, J Olivier, R Na Cancer Medicine 12 (3), 3468-3476, 2023 | 9 | 2023 |
The clinical implications and molecular mechanism of CX3CL1 expression in urothelial bladder cancer G Jiang, H Wang, D Huang, Y Wu, W Ding, Q Zhou, Q Ding, N Zhang, ... Frontiers in Oncology 11, 752860, 2021 | 9 | 2021 |
Prostate volume does not provide additional predictive value to prostate health index for prostate cancer or clinically significant prostate cancer: results from a multicenter … D Huang, YS Wu, DW Ye, J Qi, F Liu, BT Helfand, SL Zheng, Q Ding, ... Asian Journal of Andrology 22 (5), 539-543, 2020 | 9 | 2020 |
CRISPR screening reveals gleason score and castration resistance related oncodriver ring finger protein 19 A (RNF19A) in prostate cancer N Zhang, D Huang, X Ruan, ATL Ng, JHL Tsu, G Jiang, J Huang, Y Zhan, ... Drug Resistance Updates 67, 100912, 2023 | 8 | 2023 |
Genome‐Wide 3′‐UTR Single Nucleotide Polymorphism Association Study Identifies Significant Prostate Cancer Risk‐Associated Functional Loci at 8p21. 2 in Chinese Population N Zhang, D Huang, G Jiang, S Chen, X Ruan, H Chen, J Huang, A Liu, ... Advanced Science 9 (23), 2201420, 2022 | 8 | 2022 |
Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG N Giannareas, Q Zhang, X Yang, R Na, Y Tian, Y Yang, X Ruan, D Huang, ... Nature Communications 13 (1), 7320, 2022 | 7 | 2022 |
Prostate Health Index (phi) and its derivatives predict Gleason score upgrading after radical prostatectomy among patients with low-risk prostate cancer JQ Yan, D Huang, JY Huang, XH Ruan, XL Lin, ZJ Fang, Y Gao, ... Asian Journal of Andrology 24 (4), 406, 2022 | 5 | 2022 |
Application of European‐specific polygenic risk scores for predicting prostate cancer risk in different ancestry populations X Ruan, D Huang, J Huang, D Xu, R Na The Prostate 83 (1), 30-38, 2022 | 5 | 2022 |
Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinoma J Huang, D Huang, J Yan, T Chen, Y Gao, D Xu, R Na Cancer Medicine 9 (24), 9409-9418, 2020 | 5 | 2020 |
Risk of second primary cancers after a diagnosis of first primary cancer: A pan-cancer analysis and Mendelian randomization study X Ruan, D Huang, Y Zhan, J Huang, J Huang, ATL Ng, JHL Tsu, R Na Elife 12, e86379, 2023 | 4 | 2023 |
Causal Effects of Modifiable Behaviors on Prostate Cancer in Europeans and East Asians: A Comprehensive Mendelian Randomization Study Y Zhan, X Ruan, P Wang, D Huang, J Huang, J Huang, TTS Chun, ... Biology 12 (5), 673, 2023 | 3 | 2023 |